BlossomHill Therapeutics (NASDAQ:BLSM) General Counsel Vincent Paul Liptak Purchases 2,200 Shares of Stock

BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) General Counsel Vincent Paul Liptak purchased 2,200 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The shares were purchased at an average price of $16.00 per share, for a total transaction of $35,200.00. Following the purchase, the general counsel directly owned 111,412 shares in the company, valued at $1,782,592. The trade was a 2.01% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Vincent Paul Liptak also recently made the following trade(s):

• On Friday, August 7th, Vincent Paul Liptak acquired 2,500 shares of BlossomHill Therapeutics stock. The stock was purchased at an average cost of $15.80 per share, with a total value of $39,500.00.

BlossomHill Therapeutics Stock Performance

Shares of BLSM traded down $0.01 during mid-day trading on Monday, reaching $15.99. 417,968 shares of the company’s stock were exchanged. BlossomHill Therapeutics, Inc. has a 52-week low of $15.25 and a 52-week high of $17.25.